Akari Therapeutics, Plc (AKTX)
AKTX
Loading signal…
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $9M
- Beta
- 1.39
- P/E (TTM)
- -0.00
- Short % float
- 5.02%
- Days to cover
- 1.0
- SI change
- +66.2%
- 1W
- -0.66%
- 1M
- -14.14%
- 3M
- -59.11%
- YTD
- -35.60%
- vs SPY 1W
- +0.53%
- vs SPY 1M
- -17.46%
- vs SPY 3M
- -61.50%
- vs SPY YTD
- -47.36%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- NVNOSELLenVVeno Medical CorporationCRISISQ -25$10.35+0.58%
- REVBBUYRevelation Biosciences, Inc.RECOVERYQ -29$1.10+0.92%
- PREBUYPrenetics Global LimitedRECOVERYQ -10$21.82+8.02%
- MPLTSELLMapLight Therapeutics, Inc.CRISISQ -18$11.36+1.34%
- ACRVBUYAcrivon Therapeutics, Inc. Common StockRECOVERYQ -15$2.20-0.45%
- ACETBUYAdicet Bio, Inc.RECOVERYQ -27$8.90-3.16%
- ALXOSELLALX Oncology Holdings Inc.RECOVERYQ -11$1.99-2.45%
- AMLXBUYAmylyx Pharmaceuticals, Inc.RECOVERYQ 10$38.15-1.32%
- BCAXSELLBicara Therapeutics Inc. Common StockCRISISQ 0$23.58-1.34%
- CRVSBUYCorvus Pharmaceuticals, Inc.RECOVERYQ 14$14.09-2.56%
- DMACSELLDiaMedica Therapeutics Inc.RECOVERYQ 6$6.52+0.00%
- DSGNBUYDesign Therapeutics, Inc.BULLQ -10$15.23+1.60%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…